CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.94 +0.18 (6.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.76 | 52 Week High | $24.68 | |||
| Open | $2.86 | 52 Week Low | $9.10 | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $0.00 | |||
| Volume | 7,922,968 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 182.56 +9.62 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $172.94 | 52 Week High | $0.52 | |||
| Open | $168.50 | 52 Week Low | $0.08 | |||
| Day High | $187.20 | P/E | N/A | |||
| Day Low | $168.30 | EPS | $-3.80 | |||
| Volume | 24,025,037 | |||||
